Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma GONDII (original) (raw)

• Morisaki, J. H., Heuser, J. E. & Sibley, L. D. Invasion of Toxoplasma gondii occurs by active penetration of the host cell. J. Cell Sci. 108, 2457–2464 (1995). An important review of T. gondii invasion mechanisms.
  CAS PubMed Google Scholar
• Black, M. W. & Boothroyd, J. C. Lytic cycle of Toxoplasma gondii. Microbiol. Mol. Biol. Rev. 64, 607–623 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Martinez, A. J. et al. The neuropathology and epidemiology of AIDS. A Berlin experience. A review of 200 cases. Pathol. Res. Pract. 191, 427–443 (1995).
  Article CAS PubMed Google Scholar
• Hay, J. & Hutchison, W. M. Toxoplasma gondii — an environmental contaminant. Ecol. Dis. 2, 33–43 (1983).
  CAS PubMed Google Scholar
• Hunter, C. A., Subauste, C. S., Van Cleave, V. H. & Remington, J. S. Production of γ interferon by natural killer cells from _Toxoplasma gondii_-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor α. Infect. Immun. 62, 2818–2824 (1994).
  CAS PubMed PubMed Central Google Scholar
• Sher, A., Oswald, I. P., Hieny, S. & Gazzinelli, R. T. Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J. Immunol. 150, 3982–3989 (1993).
  CAS PubMed Google Scholar
• Gazzinelli, R. T. et al. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153, 2533–2543 (1994).
  CAS PubMed Google Scholar
• Denkers, E. Y. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunol. Med. Microbiol. 39, 193–203 (2003). An up-to-date review of signalling cascades that are triggered by T. gondii.
  Article CAS PubMed Google Scholar
• Reis e Sousa, C. et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186, 1819–1829 (1997).
  Article CAS PubMed Google Scholar
• Aliberti, J. et al. CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells. Nature Immunol. 1, 83–87 (2000).
  Article CAS Google Scholar
• Aliberti, J. et al. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nature Immunol. 4, 485–490 (2003). Identification of a CCR5 ligand mimic from T. gondii that activates IL-12 production by DCs.
  Article CAS Google Scholar
• Golding, H. et al. Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii. Blood 102, 3280–3286 (2003).
  Article CAS PubMed Google Scholar
• Yarovinsky, F. et al. Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii. J. Biol. Chem. 279, 53635–53642 (2004).
  Article CAS PubMed Google Scholar
• Scanga, C. A. et al. MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168, 5997–6001 (2002).
  Article CAS PubMed Google Scholar
• Scharton-Kersten, T., Contursi, C., Masumi, A., Sher, A. & Ozato, K. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J. Exp. Med. 186, 1523–1534 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Rev. Immunol. 3, 133–146 (2003). An up-to-date review of IL-12 biology.
  Article CAS Google Scholar
• Mason, N. J. et al. TRAF6-dependent mitogen-activated protein kinase activation differentially regulates the production of interleukin-12 by macrophages in response to Toxoplasma gondii. Infect. Immun. 72, 5662–5667 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Tsujimura, H. et al. ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro. Blood 101, 961–969 (2003).
  Article CAS PubMed Google Scholar
• Yap, G. S. & Sher, A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201, 240–247 (1999).
  Article CAS PubMed Google Scholar
• Karp, C. L. & Wills-Karp, M. Complement and IL-12: yin and yang. Microbes Infect. 3, 109–119 (2001).
  Article CAS PubMed Google Scholar
• Son, E. S., Song, K. J., Shin, J. C. & Nam, H. W. Molecular cloning and characterization of peroxiredoxin from Toxoplasma gondii. Korean J. Parasitol. 39, 133–141 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Salek-Ardakani, S., Arrand, J. R. & Mackett, M. Epstein–Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. Virology 304, 342–351 (2002).
  Article CAS PubMed Google Scholar
• Fiorentino, D. F. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by TH1 cells. J. Immunol. 146, 3444–3451 (1991).
  CAS PubMed Google Scholar
• Haig, D. M. Poxvirus interference with the host cytokine response. Vet. Immunol. Immunopathol. 63, 149–156 (1998).
  Article CAS PubMed Google Scholar
• van de Loo, F. A. & van den Berg, W. B. Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators. Rheum. Dis. Clin. North Am. 28, 127–149 (2002).
  Article PubMed Google Scholar
• Wille, U., Villegas, E. N., Striepen, B., Roos, D. S. & Hunter, C. A. Interleukin-10 does not contribute to the pathogenesis of a virulent strain of Toxoplasma gondii. Parasite Immunol. 23, 291–296 (2001).
  Article CAS PubMed Google Scholar
• Deckert-Schluter, M. et al. Interleukin-10 downregulates the intracerebral immune response in chronic Toxoplasma encephalitis. J. Neuroimmunol. 76, 167–176 (1997).
  Article CAS PubMed Google Scholar
• Suzuki, Y. et al. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164, 5375–5382 (2000).
  Article CAS PubMed Google Scholar
• Gazzinelli, R. T. et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J. Immunol. 157, 798–805 (1996).
  CAS PubMed Google Scholar
• Reis e Sousa, C. et al. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 11, 637–647 (1999).
  Article CAS PubMed Google Scholar
• Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C. N. & Sher, A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nature Immunol. 3, 76–82 (2002). An original report on the inhibitory effects of LXA 4 on DC function in vivo and in vitro.
  Article CAS Google Scholar
• Kieran, N. E., Maderna, P. & Godson, C. Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. Kidney Int. 65, 1145–1154 (2004).
  Article CAS PubMed Google Scholar
• Samuelsson, B. Arachidonic acid metabolism: role in inflammation. Z. Rheumatol. 50 (Suppl. 1), 3–6 (1991).
  PubMed Google Scholar
• Goh, J., Godson, C., Brady, H. R. & Macmathuna, P. Lipoxins: pro-resolution lipid mediators in intestinal inflammation. Gastroenterology 124, 1043–1054 (2003).
  Article CAS PubMed Google Scholar
• Van Dyke, T. E. & Serhan, C. N. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J. Dent. Res. 82, 82–90 (2003).
  Article CAS PubMed Google Scholar
• Bandeira-Melo, C. et al. Lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J. Immunol. 164, 2267–2271 (2000).
  Article CAS PubMed Google Scholar
• Clish, C. B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl Acad. Sci. USA 96, 8247–8252 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Hachicha, M., Pouliot, M., Petasis, N. A. & Serhan, C. N. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1α-initiated neutrophil responses and trafficking: regulators of a cytokine–chemokine axis. J. Exp. Med. 189, 1923–1930 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Ohira, T. et al. A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils. J. Immunol. 173, 2091–2098 (2004).
  Article CAS PubMed Google Scholar
• Ramstedt, U., Ng, J., Wigzell, H., Serhan, C. N. & Samuelsson, B. Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding. J. Immunol. 135, 3434–3438 (1985).
  CAS PubMed Google Scholar
• Maddox, J. F. et al. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J. Biol. Chem. 272, 6972–6978 (1997).
  Article CAS PubMed Google Scholar
• Schaldach, C. M., Riby, J. & Bjeldanes, L. F. Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 38, 7594–7600 (1999).
  Article CAS PubMed Google Scholar
• Devchand, P. R. et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 17, 652–659 (2003).
  Article CAS PubMed Google Scholar
• Leonard, M. O. et al. 15-Epi-16-(para-fluorophenoxy)-lipoxin A4-methyl ester, a synthetic analogue of 15-epi-lipoxin A4, is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol. 13, 1657–1662 (2002).
  Article CAS PubMed Google Scholar
• Alexander, W. S. & Hilton, D. J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22, 503–529 (2004).
  Article CAS PubMed Google Scholar
• Kile, B. T. et al. The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 27, 235–241 (2002).
  Article CAS PubMed Google Scholar
• Hong, S., Gronert, K., Devchand, P. R., Moussignac, R. L. & Serhan, C. N. Novel docosatrienes and 17_S_-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278, 14677–14687 (2003).
  Article CAS PubMed Google Scholar
• Serhan, C. N. et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025–1037 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Aliberti, J., Serhan, C. & Sher, A. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 196, 1253–1262 (2002). An original report on the role of endogenous lipoxins in modulating pro-inflammatory responses during infection with T. gondii.
  Article CAS PubMed PubMed Central Google Scholar
• Funk, C. D., Chen, X. S., Johnson, E. N. & Zhao, L. Lipoxygenase genes and their targeted disruption. Prostaglandins Other Lipid Mediat. 68–69, 303–312 (2002).
  Article PubMed Google Scholar
• Goulet, J. L. et al. Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice. J. Immunol. 163, 359–366 (1999).
  CAS PubMed Google Scholar
• Bannenberg, G. L., Aliberti, J., Hong, S., Sher, A. & Serhan, C. Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis. J. Exp. Med. 199, 515–523 (2004). Identification of a lipoxygenase activity in T. gondii that has immunomodulatory effects in vivo.
  Article CAS PubMed PubMed Central Google Scholar
• Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K. & Serhan, C. N. Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunol. 2, 612–619 (2001).
  Article CAS Google Scholar
• Vance, R. E., Hong, S., Gronert, K., Serhan, C. N. & Mekalanos, J. J. The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase. Proc. Natl Acad. Sci. USA. 101, 2135–2139 (2004). Identification of a 15-lipoxygenase in the cystic-fibrosis-causing pathogen P. aeruginosa.
  Article CAS PubMed PubMed Central Google Scholar
• Karp, C. L. et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nature Immunol. 5, 388–392 (2004). Identification of a defect in the generation of lipoxin in patients with cystic fibrosis.
  Article CAS Google Scholar
• Chan, J. & Flynn, J. The immunological aspects of latency in tuberculosis. Clin. Immunol. 110, 2–12 (2004).
  Article CAS PubMed Google Scholar
• Flynn, J. L. & Chan, J. Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr. Opin. Immunol. 15, 450–455 (2003). An up-to-date review on the immune-evasion mechanisms of M. tuberculosis.
  Article CAS PubMed Google Scholar